GeneDx Holdings Corp. financial data

Symbol
WGS, WGSWW on Nasdaq
Industry
Services-Health Services
Location
333 Ludlow Street, North Tower, 8 Th Floor, Stamford, Connecticut
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Sema4 Holdings Corp. (to 1/5/2023), CM Life Sciences, Inc. (to 7/21/2021)
Latest financial report
10-Q - Q2 2024 - Jul 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 276 % +40.1%
Quick Ratio 16.3 % +1.56%
Debt-to-equity 83.3 % +33%
Return On Equity -53.2 % +61.3%
Return On Assets -29 % +65.6%
Operating Margin -38.1 % +82.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.9M shares +4.51%
Common Stock, Shares, Outstanding 26.9M shares +4.52%
Entity Public Float 96M USD -56%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26.6M shares +4.72%
Weighted Average Number of Shares Outstanding, Diluted 26.6M shares +4.72%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 244M USD +3.06%
Research and Development Expense 49M USD -29.4%
Selling and Marketing Expense 65M USD -29.6%
General and Administrative Expense 100M USD -44%
Operating Income (Loss) -92.8M USD +82.4%
Nonoperating Income (Expense) -25.5M USD -176%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -118M USD +76.1%
Income Tax Expense (Benefit) -855K USD +3.06%
Net Income (Loss) Attributable to Parent -117M USD +76.2%
Earnings Per Share, Basic -4.23 USD/shares +89.4%
Earnings Per Share, Diluted -4.23 USD/shares +89.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 56.1M USD -64.2%
Marketable Securities, Current 50.8M USD
Cash, Cash Equivalents, and Short-term Investments 114M USD
Accounts Receivable, after Allowance for Credit Loss, Current 32.9M USD -12.6%
Inventory, Net 10.3M USD -10.5%
Other Assets, Current 11.4M USD
Assets, Current 162M USD -24%
Property, Plant and Equipment, Net 32.5M USD -37%
Operating Lease, Right-of-Use Asset 25.6M USD -23.9%
Intangible Assets, Net (Excluding Goodwill) 166M USD -7.81%
Goodwill 181M USD
Other Assets, Noncurrent 4.36M USD -21.6%
Assets 389M USD -18.3%
Accounts Payable, Current 8.13M USD -67.5%
Accrued Liabilities, Current 7.29M USD -56.5%
Contract with Customer, Liability, Current 40K USD -91.5%
Liabilities, Current 68.3M USD -19.1%
Deferred Income Tax Liabilities, Net 1.17M USD -48.1%
Operating Lease, Liability, Noncurrent 44.4M USD -0.09%
Other Liabilities, Noncurrent 12.7M USD -43.5%
Liabilities 195M USD +8.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 459K USD
Retained Earnings (Accumulated Deficit) -1.35B USD -9.53%
Stockholders' Equity Attributable to Parent 194M USD -34.5%
Liabilities and Equity 389M USD -18.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.4M USD +70.5%
Net Cash Provided by (Used in) Financing Activities -438K USD -100%
Net Cash Provided by (Used in) Investing Activities 843K USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 26.9M shares +4.52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16M USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 57.1M USD -63.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.02M USD +246%
Deferred Tax Assets, Valuation Allowance 272M USD +19.8%
Deferred Tax Assets, Gross 326M USD +16.2%
Operating Lease, Liability 46.8M USD -0.25%
Payments to Acquire Property, Plant, and Equipment 443K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -29M USD +37.9%
Lessee, Operating Lease, Liability, to be Paid 66.8M USD -16.6%
Property, Plant and Equipment, Gross 78.9M USD -48.4%
Operating Lease, Liability, Current 2.33M USD -3.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.21M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.39M USD -4.55%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -14.5%
Deferred Income Tax Expense (Benefit) -48.6M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20M USD -39.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.3M USD +5.78%
Deferred Tax Assets, Operating Loss Carryforwards 258M USD +29.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 718K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.27M USD +2.67%
Operating Lease, Payments 346K USD -72%
Additional Paid in Capital 1.54B USD +0.98%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 11.2M USD -77.4%
Deferred Tax Assets, Net of Valuation Allowance 54.9M USD +1.1%
Share-based Payment Arrangement, Expense 2.18M USD +17.5%
Interest Expense 3M USD +0.47%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%